OBJECTIVES: To determine the impact of cardiac complications (CdCs) on outcomes in patients with acute subarachnoid hemorrhage (SAH). PATIENTS AND METHODS: Eighty-one adult aneurysmal SAH patients with a fisher grade >1 and/or a Hunt and Hess grade >2 were recruited for this study. CdCs were defined as electrocardiogram (ECG) changes, myocardial necrosis, arrythmias, or pulmonary edema. Outcomes were assessed at 3, 6 and 12 months by telephone interview using the Modified Rankin Scale (MRS), Glasgow Outcome Scale (GOS), Barthel Index and Medical Outcome study Short Form-36 (SF-36). RESULTS: The CdCs occurred in 33% of patients. The most common CdCs were arrythmias and pulmonary edema (30%). There was no significant difference in mortality between the two groups. At 3 months there was a significant difference in the Barthel (P = 0.007) and the SF-36 (P = 0.014) with trends in the GOS (P = 0.049) and the MRS (P = 0.063). At 6 months a significant difference remained in the SF-36 (P = 0.028) and a trend in the Barthel (P = 0.069). CONCLUSION: Results show that CdCs may negatively impact outcomes in SAH patients up to 6 months following hemorrhage.
OBJECTIVES: To determine the impact of cardiac complications (CdCs) on outcomes in patients with acute subarachnoid hemorrhage (SAH). PATIENTS AND METHODS: Eighty-one adult aneurysmalSAHpatients with a fisher grade >1 and/or a Hunt and Hess grade >2 were recruited for this study. CdCs were defined as electrocardiogram (ECG) changes, myocardial necrosis, arrythmias, or pulmonary edema. Outcomes were assessed at 3, 6 and 12 months by telephone interview using the Modified Rankin Scale (MRS), Glasgow Outcome Scale (GOS), Barthel Index and Medical Outcome study Short Form-36 (SF-36). RESULTS: The CdCs occurred in 33% of patients. The most common CdCs were arrythmias and pulmonary edema (30%). There was no significant difference in mortality between the two groups. At 3 months there was a significant difference in the Barthel (P = 0.007) and the SF-36 (P = 0.014) with trends in the GOS (P = 0.049) and the MRS (P = 0.063). At 6 months a significant difference remained in the SF-36 (P = 0.028) and a trend in the Barthel (P = 0.069). CONCLUSION: Results show that CdCs may negatively impact outcomes in SAHpatients up to 6 months following hemorrhage.
Authors: Amber McAteer; Marilyn Hravnak; Yuefang Chang; Elizabeth A Crago; Matthew J Gallek; Khalil M Yousef Journal: Biol Res Nurs Date: 2017-06-19 Impact factor: 2.522
Authors: Jonathan G Zaroff; Jonathan Leong; Helen Kim; William L Young; Sean P Cullen; Vivek A Rao; Michael Sorel; Charles P Quesenberry; Steve Sidney Journal: Neurocrit Care Date: 2012-12 Impact factor: 3.210
Authors: Elizabeth Crago; Kelly Kerris; Chien-Wen J Kuo; Paula Sherwood; Marilyn Hravnak; David Crippen; Michael Horowitz Journal: Am J Crit Care Date: 2014-01 Impact factor: 2.228
Authors: Richard E Temes; Elena Tessitore; J Michael Schmidt; Andrew M Naidech; Andres Fernandez; Noeleen D Ostapkovich; Jennifer A Frontera; Katja E Wartenberg; Marco R Di Tullio; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer; Augusto Parra Journal: Neurocrit Care Date: 2010-12 Impact factor: 3.210
Authors: Sirisha Yarlagadda; Pam Rajendran; Jacob C Miss; Nader M Banki; Alexander Kopelnik; Alan H B Wu; Nerissa Ko; Adrian W Gelb; Michael T Lawton; Wade S Smith; William L Young; Jonathan G Zaroff Journal: Neurocrit Care Date: 2006 Impact factor: 3.210
Authors: J Michael Schmidt; Michael Crimmins; Hector Lantigua; Andres Fernandez; Chris Zammit; Cristina Falo; Sachin Agarwal; Jan Claassen; Stephan A Mayer Journal: Neurocrit Care Date: 2014-06 Impact factor: 3.210